- Home
- SBFM vs BYAH Comparison
SBFM vs BYAH Comparison
Compare SBFM & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBFM | BYAH |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0M | 5.3M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | SBFM | BYAH |
|---|---|---|
| Price | $1.17 | $0.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 36.6K | ★ 37.1M |
| Earning Date | 03-31-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,323,742.00 | $2,768,120.00 |
| Revenue This Year | $10.26 | N/A |
| Revenue Next Year | $32.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.24 | ★ 42.65 |
| 52 Week Low | $1.15 | $0.05 |
| 52 Week High | $3.90 | $41.49 |
Technical Indicators
Market Signals| Indicator | SBFM | BYAH |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 30.67 |
| Support Level | $1.15 | $0.05 |
| Resistance Level | $1.23 | $0.11 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 10.00 | 8.08 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.